Overview
Aleta Biotherapeutics is an immuno-oncology company founded to transform cellular therapeutics to allow a broad spectrum of tumor types to be targeted, including currently intractable solid tumors. Co-founders Paul Rennert and Roy Lobb bring extensive scientific and leadership experience in immunology, oncology and drug development to this new enterprise.